Caffeine 300 MG: Clinical Trials

4 trials of Caffeine 300 MG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 3 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Not yet recruiting 1
Phase 11Completed 1
Phase 21Completed 1

Follow Caffeine 300 MG: new trials by email Literature Review of Caffeine 300 MG trials Research Report on Caffeine 300 MG

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
5 vs 10-Minute Chewing of Caffeinated Gum: Plasma Caffeine Pharmacokinetics
Caffeine 300 MG - Caffeine
Not applicableCompletedEge University302025-04-222026-02-04
Caffeine Mouth Rinse on Salivary Immunoglobulin A, Lactoferrin and A-Amylase Levels
Caffeine 300 MG, Exercise, Placebo - Exercise Response
Not applicableNot yet recruitingUniversity of Gaziantep302024-11-152024-11-26
Effects of Caffeine on Agility in Amateur Soccer Players
Caffeine 300 MG, Placebo - Healthy Adult Male
Not applicableCompletedComenius University162024-10-212026-09-28
Caffeine and Cocaine
Caffeine 150 MG, Placebo, Amphetamine - Cocaine Dependence
Phase 1 / Phase 2CompletedVirginia Commonwealth University232008-04-012017-03-22

Conditions studied

Cocaine-Related Disorders (1)  ·  Impulsive Behavior (1)  ·  Motor Activity (1)  ·  Substance-Related Disorders (1)

Sponsors

Comenius University (1)  ·  Ege University (1)  ·  University of Gaziantep (1)  ·  Virginia Commonwealth University (1)

Countries

Slovakia (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Filip Skala, PhD. (1)  ·  Frederick G Moeller, MD (1)  ·  Hakan Arslan, Dr. (1)

Results publications

PMID 11839447, PMID 25414797

NIH funding

P50DA009262 (1)